$HRTX HERON THERAPEUTICS, INC. /DE/ Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in HERON THERAPEUTICS, INC. /DE/.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in HERON THERAPEUTICS, INC. /DE/. Insider overview, share value development, latest insider transactions and email notifications about new events in HERON THERAPEUTICS, INC. /DE/ for free.

CIK Number: 0000818033
IRS Number: 942875566
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: HRTX
Company Address: 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO 92121
Phone number: 6503662626
Former name: ADVANCED POLYMER SYSTEMS INC /DE/, date of change: 1992-07-03
Former name: ADVANCED POLYMER SYSTEMS INC /DE/, date of change: 1992-07-03
Former name: AP PHARMA INC /DE/, date of change: 2001-05-11

Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bio erodible, injectable and implantable delivery systems. Heron Therapeutics was founded in February 1983 and is headquartered in Redwood City, CA.

Prev close: $13.35
Average Daily Volume: 994,703
Days Low: $12.95
Year Low: $12.21
Year High: $25.46

HERON THERAPEUTICS, INC. /DE/ Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Christian WaageDirector1,40018,690shares bought: 1,400 / shares sold: 0 BUYMay 16 20193 days ago
MANHARD KIMBERLYExecutive VP, Drug Development1,10914,805shares bought: 60,729 / shares sold: -60,729 HOLDMay 02 201917 days ago

View all HERON THERAPEUTICS, INC. /DE/ insiders.

HERON THERAPEUTICS, INC. /DE/ Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 16 2019HRTXHERON THERAPEUTICS ...Christian WaageDirectorBuyP18.041,40025,2621,4000 to 1.4 K
May 02 2019HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...SellS18.861,10920,91801.1 K to 0 (-100.00 %)
May 02 2019HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...BuyJ18.431,10920,4371,1090 to 1.1 K
Dec 18 2018HRTXHERON THERAPEUTICS ...Rosen RobertPresidentOption ExerciseA24.97300,0007,491,000300,000
Dec 18 2018HRTXHERON THERAPEUTICS ...Quart Barry DChief Executive Off ...Option ExerciseA24.97300,0007,491,000300,000
Dec 18 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...Option ExerciseA24.97100,0002,497,000100,000
Dec 18 2018HRTXHERON THERAPEUTICS ...HOFFMAN ROBERTCFO & SVP, FinanceOption ExerciseA24.9771,0001,772,87071,000
Dec 18 2018HRTXHERON THERAPEUTICS ...Christian WaageDirectorOption ExerciseA24.9717,000424,49017,000
Dec 18 2018HRTXHERON THERAPEUTICS ...POYHONEN JOHNDirectorOption ExerciseA24.9730,000749,10030,000
Dec 18 2018HRTXHERON THERAPEUTICS ...POYHONEN JOHNDirectorOption ExerciseA24.9719,500486,91519,500
Dec 18 2018HRTXHERON THERAPEUTICS ...Johnson Craig ADirectorOption ExerciseA24.9721,000524,37021,000
Dec 18 2018HRTXHERON THERAPEUTICS ...TANG KEVIN CDirectorOption ExerciseA24.9717,000424,49017,000
Nov 02 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...SellS30.6249415,1250494 to 0 (-100.00 %)
Nov 02 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...BuyJ23.6049411,6564940 to 494
Oct 02 2018HRTXHERON THERAPEUTICS ...MANHARD KIMBERLYExecutive VP, Drug ...Option ExerciseM13.006,00078,00082,416

View all HERON THERAPEUTICS, INC. /DE/ insider transactions.